A New Combination of Testosterone and Nestorone Transdermal Gels for Male Hormonal Contraception
Author(s) -
Niloufar Ilani,
Mara Y. Roth,
John K. Amory,
Ronald S. Swerdloff,
Clint Dart,
Stephanie T. Page,
William J. Bremner,
Régine SitrukWare,
Narender Kumar,
Diana Blithe,
Christina Wang
Publication year - 2012
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-1384
Subject(s) - transdermal , male contraceptive , testosterone (patch) , placebo , sperm , medicine , spermatogenesis , adverse effect , randomized controlled trial , endocrinology , andrology , gynecology , population , pharmacology , family planning , research methodology , alternative medicine , environmental health , pathology
Combinations of testosterone (T) and nestorone (NES; a nonandrogenic progestin) transdermal gels may suppress spermatogenesis and prove appealing to men for contraception.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom